Shigeki Sugii leads the Laboratory of Fat Metabolism and Stem Cells under the Cell Biology & Therapies Division at the Institute of Molecular and Cell Biology (IMCB). Sugii also holds a joint appointment at Duke-NUS Medical School. Before joining IMCB, he was a Group Leader at A*STAR’s Singapore Bioimaging Consortium (SBIC) from 2011-2019 and at A*STAR’s Institute of Bioengineering and Bioimaging (IBB) from 2019-2021. Sugii graduated with a B.S. in Agricultural Chemistry from Kyoto University, Japan and received his Ph.D. in Biochemistry at Dartmouth Medical School, USA. He then moved to the Salk Institute for Biological Studies and Howard Hughes Medical Institute, USA to conduct his postdoctoral research with Prof. Ronald Evans. Sugii serves as an executive committee member (Secretary) of the Stem Cell Society Singapore and on several other scientific committees. He was a co-founder of Celligenics Pte. Ltd. and recently founded ImpacFat Pte. Ltd. in Singapore.
